These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31648371)

  • 1. Managing Parkinson's disease: moving ON with NOP.
    Mercatelli D; Bezard E; Eleopra R; Zaveri NT; Morari M
    Br J Pharmacol; 2020 Jan; 177(1):28-47. PubMed ID: 31648371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOP Receptor Ligands and Parkinson's Disease.
    Mercatelli D; Pisanò CA; Novello S; Morari M
    Handb Exp Pharmacol; 2019; 254():213-232. PubMed ID: 30689087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
    J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
    Arcuri L; Viaro R; Bido S; Longo F; Calcagno M; Fernagut PO; Zaveri NT; Calò G; Bezard E; Morari M
    Neurobiol Dis; 2016 May; 89():55-64. PubMed ID: 26804029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
    Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
    J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.
    Marti M; Mela F; Fantin M; Zucchini S; Brown JM; Witta J; Di Benedetto M; Buzas B; Reinscheid RK; Salvadori S; Guerrini R; Romualdi P; Candeletti S; Simonato M; Cox BM; Morari M
    J Neurosci; 2005 Oct; 25(42):9591-601. PubMed ID: 16237164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.
    Volta M; Viaro R; Trapella C; Marti M; Morari M
    Exp Neurol; 2011 Mar; 228(1):126-37. PubMed ID: 21215744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
    Marti M; Rodi D; Li Q; Guerrini R; Fasano S; Morella I; Tozzi A; Brambilla R; Calabresi P; Simonato M; Bezard E; Morari M
    J Neurosci; 2012 Nov; 32(46):16106-19. PubMed ID: 23152595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems.
    Norton CS; Neal CR; Kumar S; Akil H; Watson SJ
    J Comp Neurol; 2002 Mar; 444(4):358-68. PubMed ID: 11891648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
    Marti M; Trapella C; Morari M
    J Neurochem; 2008 Dec; 107(6):1683-96. PubMed ID: 19014386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
    Gavioli EC; de Medeiros IU; Monteiro MC; Calo G; Romão PR
    Vitam Horm; 2015; 97():241-66. PubMed ID: 25677775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.
    Di Benedetto M; Cavina C; D'Addario C; Leoni G; Candeletti S; Cox BM; Romualdi P
    Neuropharmacology; 2009 Mar; 56(4):761-7. PubMed ID: 19162046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS; Marti M; Morari M
    Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R; Calcagno M; Marti M; Borrelli E; Morari M
    Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
    Pisanò CA; Mercatelli D; Mazzocchi M; Brugnoli A; Morella I; Fasano S; Zaveri NT; Brambilla R; O'Keeffe GW; Neubig RR; Morari M
    Br J Pharmacol; 2023 Apr; 180(7):927-942. PubMed ID: 34767639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
    Liao YY; Lee CW; Ho IK; Chiou LC
    Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease.
    Bastías-Candia S; Di Benedetto M; D'Addario C; Candeletti S; Romualdi P
    Environ Toxicol; 2015; 30(6):656-63. PubMed ID: 24376148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours.
    Al Yacoub ON; Zhang Y; Patankar PS; Standifer KM
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.